Drug Name Neurontin

PGE2 and PGI2 produce arteriolar vasodilation; PGF2?, venoconstriction. Gastric secretion. PG promote the production of gastric mucus and reduce the formation of gastric acid (p. 160). Menstruation. PGF2? is believed to be responsible for the ischemic necrosis of the endometrium preceding menstruation.
It is the drug of choice in the treatment of angina pectoris attacks. For this purpose, it is administered as a spray, or in sublingual or buccal tablets for transmucosal delivery. The onset of action is between 1 and 3 min. Due to a nearly complete presystemic elimination, it is poorly suited for oral administration.

 

Fluid retention leads to an increase in body weight and, possibly, edemas. These counter-regulatory processes are susceptible to pharmacological inhibition (?-blockers, ACE inhibitors, AT1-antagonists, diuretics). Mechanisms of action. The tonus of vascular smooth muscle can be decreased by various means.
A significant amount of glucose enters extrahepatic tissues, where it has to be utilized. In overweight adults, a diabetic metabolic condition may develop (type II or non-insulin-dependent diabetes) when there is a relative insulin deficiency— enhanced demand cannot be met by a diminishing insulin secretion.